当前位置:首页 - 行情中心 - 华恒生物(688639) - 财务分析

华恒生物

(688639)

  

流通市值:88.54亿  总市值:88.54亿
流通股本:2.50亿   总股本:2.50亿

华恒生物(688639)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.59亿元,每股收益0.67元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益266770.17万元,未分配利润118522.41万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产567166.53万元,负债300396.36万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,193,542,266.711,489,160,461.14687,062,042.252,177,940,839.23
营业总成本2,022,179,740.121,361,608,565.23632,740,817.632,017,012,228.65
其他经营收益
营业利润174,450,674.85121,375,747.1355,201,014.43199,316,773.49
利润总额171,328,066.51118,568,919.6454,682,602.75201,405,008.54
净利润159,424,732.82109,148,765.6749,138,959.43184,557,880.58
每股收益
其他综合收益-253,721.72-78,859.73-15,972.35238,507.11
综合收益总额159,171,011.1109,069,905.9449,138,959.43184,796,387.69
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,654,263,099.651,452,801,954.171,444,126,941.51,351,747,095.09
非流动资产:
非流动资产合计4,017,402,181.773,848,819,905.43,708,700,831.713,637,657,788.1
资产总计5,671,665,281.425,301,621,859.575,152,827,773.214,989,404,883.19
流动负债:
流动负债合计1,145,168,292.321,328,312,593.031,403,507,432.861,603,530,015.65
非流动负债:
非流动负债合计1,858,795,313.241,355,708,695.841,140,972,193.52827,496,697.52
负债合计3,003,963,605.562,684,021,288.872,544,479,626.382,431,026,713.17
所有者权益(或股东权益):
归属于母公司股东权益合计2,682,169,896.032,629,615,367.512,616,576,699.352,564,649,586.26
股东权益合计2,667,701,675.862,617,600,570.72,608,348,146.832,558,378,170.02
负债和股东权益合计5,671,665,281.425,301,621,859.575,152,827,773.214,989,404,883.19
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,252,920,988.181,492,091,877.78679,163,469.132,463,588,278.69
经营活动现金流出小计2,138,179,477.181,417,360,182.02663,442,384.862,263,793,667.06
经营活动产生的现金流量净额114,741,51174,731,695.7615,721,084.27199,794,611.63
投资活动产生的现金流量:
投资活动现金流入小计37,856.717,558.7560,0003,615,152.04
投资活动现金流出小计404,489,353.24261,450,489.3195,099,462.7933,710,013.72
投资活动产生的现金流量净额-404,451,496.54-261,432,930.61-94,539,462.7-930,094,861.68
筹资活动产生的现金流量:
筹资活动现金流入小计1,458,093,321.39797,283,387.65396,621,603.932,450,192,540.45
筹资活动现金流出小计1,092,135,582.08647,734,465.18321,322,280.481,669,442,939.33
筹资活动产生的现金流量净额365,957,739.31149,548,922.4775,299,323.45780,749,601.12
汇率变动对现金及现金等价物的影响1,745,348.31,463,668.066,481,912.6612,015,901.05
现金及现金等价物净增加额77,993,102.07-35,688,644.322,962,857.6862,465,252.12
期末现金及现金等价物余额492,952,452.97379,270,706.58417,922,208.58414,959,350.9
补充资料:
现金及现金等价物的净增加额--35,688,644.32-62,465,252.12
最新报告期:2025-09-15
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长城证券王彤,肖亚平0.961.191.522025-09-15
国海证券李永磊,杨丽蓉,董伯骏0.981.391.902025-09-10
华安证券刘天其,王强峰1.061.491.912025-09-04
长江证券马太,王岭峰1.131.542.582025-08-31
中金公司王天鹤,裘孝锋0.800.99--2025-08-30
TOP↑